Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
NEUROMETRIX INC (NURO) Stock Price & Overview
NASDAQ:NURO • US6412558800
Current stock price
4.58 USD
+0.22 (+5.05%)
At close:
4.53 USD
-0.05 (-1.09%)
After Hours:
The current stock price of NURO is 4.58 USD. Today NURO is up by 5.05%. In the past month the price increased by 3.6%. In the past year, price increased by 6.51%.
NURO Key Statistics
52-Week Range2.66 - 4.73
Current NURO stock price positioned within its 52-week range.
1-Month Range4.26 - 4.69
Current NURO stock price positioned within its 1-month range.
- Market Cap
- 9.435M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -4.03
- Dividend Yield
- N/A
NURO Stock Performance
Today
+5.05%
1 Week
+4.69%
1 Month
+3.60%
3 Months
+6.26%
Longer-term
6 Months +14.50%
1 Year +6.51%
2 Years -43.32%
3 Years -86.96%
5 Years -72.48%
10 Years -99.83%
NURO Stock Chart
NURO Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to NURO. When comparing the yearly performance of all stocks, NURO is one of the better performing stocks in the market, outperforming 79.56% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
NURO Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NURO. NURO has a great financial health rating, but its profitability evaluates not so good.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
NURO Earnings
Next Earnings DateMay 13, 2025
Last Earnings DateFeb 20, 2025
PeriodQ4 / 2024
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %
NURO Forecast & Estimates
Analysts
Analysts82.86
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
NURO Financial Highlights
Over the last trailing twelve months NURO reported a non-GAAP Earnings per Share(EPS) of -4.03. The EPS decreased by -98.82% compared to the year before.
Income Statements
Revenue(TTM)3.03M
Net Income(TTM)-7.81M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -50.94% | ||
| ROE | -54.54% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%38.94%
Sales Q2Q%-55.77%
EPS 1Y (TTM)-98.82%
Revenue 1Y (TTM)-48.58%
NURO Ownership
Ownership
Inst Owners10.91%
Shares2.06M
Float1.75M
Ins Owners14.78%
Short Float %N/A
Short RatioN/A
NURO Industry Overview
NURO operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
60/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
22%
Outperformed 22% of sub-industries
3 Month Rank
14%
Outperformed 14% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 127
- New Highs
- 2.4%
- New Lows
- 14.2%
- Average ROE
- 17.2%
- Average Profit Margin
- 20.3%
- Average Operating Margin
- 22.5%
- Average P/E
- 28.1
- Average Fwd P/E
- 27.3
- Average Debt/Equity
- 0.5
NURO Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 39.25 | 162.529B | ||
| ABT | ABBOTT LABORATORIES | 14.24 | 157.763B | ||
| SYK | STRYKER CORP | 17.41 | 120.688B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.31 | 85.619B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.9 | 48.141B | ||
| IDXX | IDEXX LABORATORIES INC | 38.32 | 44.539B | ||
| BDX | BECTON DICKINSON AND CO | 10.94 | 42.438B | ||
| RMD | RESMED INC | 16.7 | 31.148B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 10.74 | 27.761B | ||
| DXCM | DEXCOM INC | 20.18 | 22.918B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.11 | 15.956B | ||
| PEN | PENUMBRA INC | 63.83 | 12.837B | ||
| GMED | GLOBUS MEDICAL INC - A | 20.03 | 12.197B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NURO
Company Profile
NeuroMetrix, Inc. engages in the development and manufacture of diagnostic and therapeutic neurostimulation-based medical devices. The company is headquartered in Waltham, Massachusetts and currently employs 13 full-time employees. The company went IPO on 2004-07-22. The firm's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The firm has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. The company operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.
Company Info
IPO: 2004-07-22
NEUROMETRIX INC
1000 Winter Street
Waltham MASSACHUSETTS 01801 US
CEO: Shai N. Gozani
Employees: 13
Phone: 17818909989
NEUROMETRIX INC / NURO FAQ
Can you describe the business of NEUROMETRIX INC?
NeuroMetrix, Inc. engages in the development and manufacture of diagnostic and therapeutic neurostimulation-based medical devices. The company is headquartered in Waltham, Massachusetts and currently employs 13 full-time employees. The company went IPO on 2004-07-22. The firm's products are wearable or hand-held medical devices enabled by proprietary consumables and software solutions that include mobile apps, enterprise software and cloud-based systems. The firm has two commercial brands. Quell is a wearable neuromodulation platform. DPNCheck is a point-of-care screening test for peripheral neuropathy. The company operates two product categories: Diagnostic technology and Therapeutic technology. Diagnostic technology product category is engaged in point-of-care peripheral neuropathy assessment. Therapeutic technology product category is engaged in wearable neuromodulation for chronic pain syndromes. Its patients control and personalize the technology via a mobile phone application, and their utilization and certain clinical metrics may be tracked in the Quell Health Cloud.
Can you provide the latest stock price for NEUROMETRIX INC?
The current stock price of NURO is 4.58 USD. The price increased by 5.05% in the last trading session.
Does NEUROMETRIX INC pay dividends?
NURO does not pay a dividend.
What is the ChartMill rating of NEUROMETRIX INC stock?
NURO has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What sector and industry does NEUROMETRIX INC belong to?
NEUROMETRIX INC (NURO) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the market capitalization of NURO stock?
NEUROMETRIX INC (NURO) has a market capitalization of 9.43M USD. This makes NURO a Nano Cap stock.